Virulence factors of helicobacter pylori: A review

Clinical Medicine Insights: Gastroenterology

Volumn 7, Issue , 2014, Pages 9-27

  Roesler, Bruna M ^a   Rabelo Gonçalves, Elizabeth M A ^a   Zeitune, José M R ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chronic gastritis; Gastric adenocarcinoma; Helicobacter pylori; Peptic ulcer disease; Virulence factors

Indexed keywords

CAGA PROTEIN; OUTER INFLAMMATORY PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; UREASE; VACUOLATING TOXIN; VIRULENCE FACTOR;

BACTERIAL GENE; BACTERIAL GENOME; BLOOD GROUP ANTIGEN BINDING ADHESION GENE; CAGA GENE; CHRONIC GASTRITIS; DUODENAL ULCER PROMOTING GENE; DUODENUM ULCER; DYSPEPSIA; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INDUCED BY CONTACT WITH EPITHELIUM GENE; MARGINAL ZONE LYMPHOMA; NONHUMAN; PEPTIC ULCER; REVIEW; SIALIC ACID BINDING ADHESION GENE; STOMACH ADENOCARCINOMA; STOMACH CANCER; VACUOLATING CYTOTOXIN GENE;

EID: 84897407617     PISSN: 11795522     EISSN: 11795522     Source Type: Journal    
DOI: 10.4137/CGast.S13760     Document Type: Review

References (137)

1. Goodwin CSR, Armstrong JA. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol. 1990;9(1):1-13.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311-1315.
3. Moodley Y, Linz B, Yamaoka Y, et al. The peopling of the Pacific from a bacterial perspective. Science. 2009;323(5913):527-530.
4. Falush D, Wirth T, Linz B, et al. Traces of human migration in Helicobacter pylori populations. Science. 2003;299(5612):1582-1585.
5. Suerbaum S, Michetti P. Helicobacter pylori infection. N Eng J Med. 2002;347(15): 1175-1186.
6. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113(3):321-333.
7. Urita Y, Watanabe T, Kawagoe N, et al. Role of infected grandmothers in transmission of Helicobacter pylori to children in a Japanese rural town. J Paediatr Child Health. 2013;49(5):394-398.
8. Bastos J, Carreira H, La Vecchia C, Lunet N. Childcare attendance and Helicobacter pylori infection: systematic review and meta-analysis. Eur J Cancer Prev. 2013;22(4):311-319.
9. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1998;284(5418):1328-1333.
10. Han FC, Ng HC, Ho B. Stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori. World J Gastroenterol. 2003;9(9):2021-2024.
11. Kabir S. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter. 2009;14(3):159-171.
12. Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449-490.
13. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61. World Health Organization, International Agency for Research on Cancer. 1994:1-241.
14. Capurso G, Lahner E, Marcheggiano A, et al. Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anemia associated with Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15(11):1753-1761.
15. Pelicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A. Helicobacters and extragastric diseases. Helicobacter. 2009;14(suppl 1):58-68.
16. Arnold DM, Bernotas A, Nazi I, et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 2009;94(6):850-856.
17. Franceschi F, Navarese EP, Mollo R, et al. Helicobacter pylori and atherosclerosis. A review of the literature. Recent Progr Med. 2009;100(2):91-96.
18. Rogha M, Nikvarz M, Pourmoghaddas Z, Shirneshan K, Dadkhah D, Pourmoghaddas M. Is Helicobacter pylori infection a risk factor for coronary heart disease? ARYA Atheroscler. 2012;8(1):5-8.
19. Isaeva GSH, Abuzarova ER, Valeeva IUV, Pozdeev OK, Murav́eva EV. Helicobacter pylori in patients with disorders of hepatobiliary system. Zh Mikrobiol Epidemiol Immunobiol. 2009;2:96-101.
20. Pirouz T, Zounubi L, Keivani H, Rakhshani N, Hormazdi M. Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method. Dig Dis Sci. 2009;54(7):1456-1459.
21. Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Res Clin Pract. 2013;99(2):200-208.
22. Shin DW, Kwon HT, Kang JM, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol. 2012;46(10):840-845.
23. El-Omar EM, Carrington M, Chow WH, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature. 2001;412(6842):99.
24. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 2003;125(2):364-371.
25. Gao LB, Rao I, Wang YY, et al. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis. 2009;30(2):295-299.
26. Hold GL, Rabkin CS, Chow WH, et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology. 2007;132(3):905-912.
27. Hamada GS, Kowalski LP, Nishimoto IN, et al. Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. Jpn J Clin Oncol. 2002;32(8):284-290.
28. Chen H, Tucker KL, Graubard BI, et al. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer. 2002;42(1):33-40.
29. Hara M, Hanaoka T, Kobayashi M, et al. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer. 2003;46(2):138-147.
30. Nomura AM, Hankin JH, Kolonel LN, Wilkens LR, Goodman MT, Stemmermann GN. Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control. 2003;14(6):547-558.
31. Lagiou P, Samoli E, Lagiou A, et al. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control. 2004;15(1):67-72.
32. De Stefani E, Correa P, Boffetta P, Deneo-Pellegrini H, Ronco AL, Mendilaharsu M. Dietary patterns and risk of gastric cancer: a case-control study in Uruguay. Gastric Cancer. 2004;7(4):211-220.
33. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965;64:31-49.
34. Rocco A, Nardone G., Diet, H. pylori infection and gastric cancer: evidence and controversies. World J Gastroenterol. 2007;13(21):2901-2912.
35. La TG, Chiaradia G, Gianfagna F, et al. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori. 2009;95(1):13-22.
36. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997;72(4):565-573.
37. Gonzalez CA, Pera G, Agudo A, et al. Smoking and the risk of gastric câncer in he European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2003;107(4):629-634.
38. Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19(7):689-701.
39. Malf herteiner P, Bornschein J, Selgrad M. Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention. J Dig Dis. 2010;11(1):2-11.
40. Yamaoka Y. Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis. J Med Microbiol. 2008;57(5):545-553.
41. Censini S, Lange C, Xiang Z, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996;93(25):14648-14653.
42. de Vries N, Duinsbergen D, Kuipers EJ, et al. Transcriptional phase variation of a type III restriction-modification system in Helicobacter pylori. J Bacteriol. 2002;184(23):6615-6623.
43. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388(6642):539-547.
44. Alm RA, Ling LS, Moir DT, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999; 397(6715):176-180.
45. Oh JD, Kling-Backhed H, Giannakis M, et al. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci U S A. 2006;103(26):999-1004.
46. Srikhanta YN, Gorrell RJ, Steen JA, et al. Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS ONE. 2011;6(12):e27569.
47. Alm RA, Bina J, Andrews BM, Doig P, Hancock RE, Trust TJ. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun. 2000;68(7):4155-68.
48. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279(5349):373-377.
49. Mahdavi J, Sondén B, Hurtig M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science. 2002;297(5581):573-578.
50. Peck B, Ortkamp M, Diehl KD, Hundt E, Knapp B. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res. 1999;27(16):3325-3333.
51. Pride DT, Meinersmann RJ, Blaser MJ. Allelic variation within Helicobacter pylori babA and babB. Infect Immun. 2001;69(2):1160-1171.
52. Lu H, Wu JY, Beswick EJ, et al. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesion from Western and East Asian strains. J Biol Chem. 2007;282(9):6242-6254.
53. Covacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med. 2000;191(4):587-592.
54. Rohde M, Puls J, Buhrdorf R, Fischer W, Haas R. A novel sheated surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol. 2003;49(1):219-234.
55. Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol. 2008;10(8):1573-1581.
56. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fisher W, Haas R. T{stroke}ranslocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287(5457):1497-1500.
57. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295(5555):683-686.
58. Franco AT, Israel DA, Washington MK, et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A. 2005;102(30):10646-19651.
59. Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the b-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617-4626.
60. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 2003;300(5624):1430-1434.
61. Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med. 2005;202(9):1235-1247.
62. Franco AT, Johnston E, Krishna U, et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008;68(2):379-387.
63. Brandt S, Kwok T, Hartig R, Konig W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A. 2005;102(26):9300-9305.
64. Figueiredo C, van Doorn LJ, Nogueira C, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001;36(2):128-135.
65. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55(10):2111-2115.
66. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis. Importance of the cagA status. J Natl Cancer Inst. 1995; 87(23):1777-1780.
67. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40(3):297-301.
68. Wang SH, Zhu HF, He BS, et al. cagA + H. pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis. World J Gastroenterol. 2007;13(21):2923-2931.
69. Roesler BM, Costa SCB, Zeitune JMR. Virulence factors of Helicobacter pylori and their relationship with the development of early and advanced distal intestinal type gastric adenocarcinoma. In: Tonino P, ed. Gastritis and Gastric Cancer. New Insights in Gastroprotection, Diagnosis and Treatments. Rijeka, Croatia: InTech Publishers. 2011.
70. van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998;115(1):58-66.
71. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham D. Relationship between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999;37(7):2274-2279.
72. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nature Rev Cancer. 2004;4(9):688-694.
73. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol. 2009;44(4):239-248.
74. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2011;7(11):629-641.
75. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDA immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993;90(12):5791-5795.
76. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high molecular- mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61(5):1799-1809.
77. Höcker M, Hohenberger P. Helicobacter pylori virulence factors-one part of a big picture. Lancet. 2003; 362(9391):1231-1233.
78. Miehlke S, Kirsch S, Agha-Amiri K, et al. The Helicobacter pylori vacA s1m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer. 2000;87(3):322-327.
79. Leanza AG, Mateo MJ, Crespo O, Antello P, Olmos J, Catalano M. Genetic characterisation of Helicobacter pylori isolates from an Argentinean adult population based on cag pathogenicity island right-end motifs, ispA-glmM polymorphism and iceA and vacA genotypes. Clin Microbiol Infect. 2004;10(9):811-819.
80. Ghiara P, Marchetti M, Blaser MJ, Tummuru MK, Cover TL, Segal ED. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun. 1995;63(10):4154-4160.
81. Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997;112(1):92-99.
82. Schöttker B, Adamu MA, Weck MN, Müller H, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population- based cohort study. Atherosclerosis. 2012;220(2):569-574.
83. Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid. 2013;23(10):1294-1300.
84. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124(1):91-96.
85. Kodama M, Kitadai Y, Ito M, et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter. 2007;12(1):36-42.
86. Boonyanugomol W, Chomvarin C, Sripa B, et al. Molecular analysis of Helicobacter pylori virulent-associated genes in hepatobiliary patients. HPB (Oxford). 2012;14(11):754-763.
87. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988; 26(2):93-99.
88. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology. 2008;134(1):306-323.
89. Wroblenski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713-739.
90. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995;270(30):17771-17777.
91. Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J Biol Chem. 2007; 278(29):26734-26741.
92. Rhead JL, Letley DP, Mohammadi M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007;133(3):926-936.
93. Lopez-Vidal Y, Ponce-de-Leon S, Castillo-Rojas G, Barreto-Zuniga R, Torre- Delgadillo A. High diversity of vacA and cagA Helicobacter pylori genotypes in patients with and without gastric cancer. PLoS ONE. 2008;3:e3849.
94. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7(11):629-641.
95. Basso D, Zambon CF, Letley DP, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology. 2008;135(1):91-99.
96. Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect. 2009;15(9):835-842.
97. Yamaoka Y, Orito E, Mizokami M, et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 2002;517(1-3):180-184.
98. Uchida T, Nguyen LT, Takayama A, et al. Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population. BMC Microbiol. 2009;9:175.
99. Ogiwara H, Graham DY, Yamaoka Y. vacA i-region subtyping. Gastroenterology. 2008;134(4):1267.
100. Lu H, Hsu P, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005;128(4):833-848.
101. Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H. The Helicobacter pylori duodenal ulcer promoting gene, dupA, in China. BMC Gastroenterol. 2008;8:49-54.
102. Argent RH, Burette A, Miendje Deyi VY, Atherton JC. The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China or North America. Clin Infect Dis. 2007; 45(9):1204-1206.
103. Schmidt HMA, Andres S, Kaakoush NO, et al. The prevalence of the duodenal ulcer promoting gene (dupA) in Helicobacter pylori isolates varies by ethnic group and is not universally associated with disease development: a case-control study. Gut Pathog. 2009;1(1):5-13.
104. Arachchi HSJ, Kalra V, Lal B, et al. Prevalence of duodenal ulcer promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population. Helicobacter. 2007;12(6):591-597.
105. Gomes LI, Rocha GA, Rocha AMC, et al. Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal diseases in Brazilian patients. Int J Med Microbiol. 2007;298(3-4):223-230.
106. Pacheco AR, Proença-Módena JL, Sales AIL, et al. Involvement of the Helicobacter pylori plasticity region and cag pathogenicity island genes in the development of gastroduodenal diseases. Eur J Clin Microbiol Infect Dis. 2008;27(11): 1053-1059.
107. Wang MY, Chen C, Gao XZ, et al. Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in a region at high risk of gastric cancer. Microb Pathog. 2013;59-60:13-18.
108. Douraghi M, Mohammadi M, Oghalaie A, et al. DupA as a risk determinant in Helicobacter pylori infection. J Med Microbiol. 2008;57(pt 5):554-562.
109. Shiota S, Matsunari O, Watada M, Hanada K, Yamaoka Y. Systematic review and meta-analysis: the relationship between the Helicobacter pylori dupA gene and clinical outcomes. Gut Pathog. 2010;2(1):13.
110. Gressmann H, Linz B, Ghai R, et al. Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet. 2005;1(4):e43.
111. Peek RM Jr, Thompson SA, Donahue JP, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians. 1998;110(6):531-44.
112. Xu Q, Morgan RD, Roberts RJ, et al. Functional analysis of iceA1, a CATG- recognizing restriction endonuclease gene in Helicobacter pylori. Nucleic Acids Res. 2002;30(17):3839-3847.
113. Shiota S, Watada M, Osamu M, Iwatani S, Suzuki R, Yamaoka Y. Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS ONE. 2012;7(1):e30354.
114. Amjad N, Osman HA, Razak NA, Kassian J, Din J, Abdullah NB. Clinical significance of Helicobacter pylori cagA and iceA genotype status. World J Gastroenterol.2010;16(35):4443-4447.
115. Montecucco C, Rapuolli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol. 2001;2(6):457-466.
116. Megraud F, Neman-Simha, Brugmann D. Further evidence of the toxic effect of ammonia produced by Helicobacter pylori urease on human epithelial cells. Infect Immun. 1992;60(5):1858-1863.
117. Suzuki M, Miura S, Suematsu M, et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am J Physiol. 1992;263(5 pt 1):G719-G725.
118. Harris PR, Mobley HL, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology. 1996;111(2):419-425.
119. Shao SH, Wang H, Chai SG, Liu LM. Research progress on Helicobacter pylori outer membrane protein. World J Gastroenterol. 2005;11(20):3011-3013.
120. Odenbreit S, Swoboda K, Barwig I, et al. Outer membrane protein expression profile in Helicobacter pylori clinical isolates. Infect Immun. 2009;77(9): 3782-3790.
121. Dossumbekova A, Prinz C, Mages J, et al. Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis. 2006;194(10):1346-1355.
122. Abadi ATB, Taghvaei T, Mobarez AM, Vaira G, Vaira D. High correlation of babA2-positive strains of Helicobacter pylori with the presence of gastric cancer. Intern Emerg Med. 2013;8(6):497-501.
123. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A. 1999;96(22):12778-12783.
124. Costa C, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2009;14(suppl 1):15-20.
125. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol. 2003;56(4):287-291.
126. Toller IM, Neelsen KJ, Steger M, et al. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A. 2011;108(36):14944-14949.
127. Aspholm M, Olfat FO, Nordén J, et al. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog. 2006;2(10):e110.
128. Petersson C, Forsberg M, Aspholm M, et al. Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down- regulated by the neutrophil-activating protein. Med Microbiol Immunol. 2006; 195(4):195-206.
129. Yamaoka Y, Kodama T, Graham DY, Kashima K. Search for putative virulence factors of Helicobacter pylori: the low-molecular-weight (33-35 K) antigen. Dig Dis Sci. 1998;43(7):1482-1487.
130. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A. 2000;97(13):7533-7538.
131. Ando T, Peek RM, Pride D, et al. Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status. J Clin Microbiol. 2002;40(1):239-246.
132. Kudo T, Nurgalieva ZZ, Conner ME, et al. Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol. 2004;42(5):2279-2281.
133. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005;21(6):653-659.
134. Wu JY, Lu H, Sun Y, Graham DY, Cheung HS, Yamaoka Y. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 2006;66(10): 5111-5120.
135. Tabassam FH, Graham DY, Yamaoka Y. OipA plays a role in Helicobacter pylori- induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol. 2008;10(4):1008-1020.
136. Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell. 2005;16(10):495449-495466.
137. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002;123(2): 414-424.